Corindus Vascular Robotics, Inc. (CVRS) EPS Estimated At $-0.05

October 13, 2018 - By Darrin Black

Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) Logo

Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.05 EPS on November, 6.They anticipate $0.01 EPS change or 25.00 % from last quarter’s $-0.04 EPS. After having $-0.06 EPS previously, Corindus Vascular Robotics, Inc.’s analysts see -16.67 % EPS growth. The stock increased 2.34% or $0.03 during the last trading session, reaching $1.31. About 229,388 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has declined 26.71% since October 13, 2017 and is downtrending. It has underperformed by 42.33% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $247.54 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>